Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1700
-0.0050 (-2.86%)
Oct 9, 2025, 2:59 PM EDT
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 22.59 million as of October 10, 2025. Its market cap has increased by 20.82% in one year.
Market Cap
22.59M
Enterprise Value
27.79M
Revenue
2.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 22.59M, a decrease of -64.58%. That is a compound annual growth rate of -14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 23.25M | -17.71% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | 25.41M | -13.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.35B |
| Green Thumb Industries | 2.92B |
| Trulieve Cannabis | 2.37B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.76B |
| WELL Health Technologies | 1.41B |
| Cronos Group | 1.36B |
| Extendicare | 1.26B |